$PUBC
PureBase Corp Stock $pubc

$pubc Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224008171 Filed on February 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$0.00	$0.00	$325.9K
YoY Change	-100.0%	-100.0%	-30.9%
Cost Of Revenue	$0.00	$3.000K	$96.15K
YoY Change	-100.0%	-54.82%	-27.3%
Gross Profit	$0.00	-$3.000K	$229.7K
YoY Change	-100.0%	-128.76%	-32.31%
Gross Profit Margin			70.5%
Selling, General & Admin	$461.8K	$433.6K	$1.541M
YoY Change	-92.16%	-92.56%	-95.31%
% of Gross Profit			670.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00		$0.00
YoY Change
% of Gross Profit			0.0%
Operating Expenses	$461.8K	$433.6K	$8.933M
YoY Change	-92.19%	-92.56%	-72.94%
Operating Profit	-$461.8K	-$436.6K	-$8.703M
YoY Change	-92.12%	-92.5%	-73.26%
Interest Expense	-$29.22K	-$30.72K	$76.94K
YoY Change	-420.29%	328.45%	167.94%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$618.0K	-$384.5K
YoY Change	-100.0%		908.95%
Pretax Income	-$491.0K	-$1.085M	-$9.087M
YoY Change	-91.58%	-81.37%	-72.11%
Income Tax
% Of Pretax Income
Net Earnings	-$491.0K	-$1.085M	-$9.087M
YoY Change	-91.58%	-81.37%	-72.11%
Net Earnings / Revenue			-2788.59%
Basic Earnings Per Share	$0.00		-$0.04
Diluted Earnings Per Share	$0.00	$0.00	-$0.04
COMMON SHARES
Basic Shares Outstanding	239.7M shares	230.9M shares	230.7M shares
Diluted Shares Outstanding	233.7M shares		230.7M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.760K	$5.570K	$5.570K
YoY Change	-73.11%	-70.78%	-70.78%
Cash & Equivalents	$5.760K	$5.572K
Short-Term Investments
Other Short-Term Assets	$52.54K	$15.43K	$15.43K
YoY Change	1675.0%	226.22%	226.22%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$58.30K	$21.01K	$21.01K
YoY Change	-25.5%	-11.69%	-11.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$750.7K	$750.7K	$790.5K
YoY Change	21.08%	21.08%	13.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$750.7K	$790.5K	$790.5K
YoY Change	8.86%	13.0%	12.99%
TOTAL ASSETS
Total Short-Term Assets	$58.30K	$21.01K	$21.01K
Total Long-Term Assets	$750.7K	$790.5K	$790.5K
Total Assets	$809.0K	$811.5K	$811.5K
YoY Change	5.35%	12.18%	12.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$190.1K	$314.5K	$321.9K
YoY Change	30.78%	945.62%	178.78%
Accrued Expenses	$126.5K	$200.0K	$200.0K
YoY Change	221.26%	414.33%	414.33%
Deferred Revenue
YoY Change
Short-Term Debt	$927.9K	$355.5K	$355.5K
YoY Change	4856.46%	561.67%	561.67%
Long-Term Debt Due	$25.00K	$19.00K	$19.00K
YoY Change	-40.48%	-47.22%	-47.22%
Total Short-Term Liabilities	$1.784M	$1.514M	$1.514M
YoY Change	142.42%	135.12%	135.12%
LONG-TERM LIABILITIES
Long-Term Debt	$103.0K	$1.526M	$1.526M
YoY Change	-88.79%	149.75%	149.75%
Other Long-Term Liabilities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$103.0K	$1.526M	$1.526M
YoY Change	-89.16%	134.08%	134.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.784M	$1.514M	$1.514M
Total Long-Term Liabilities	$103.0K	$1.526M	$1.526M
Total Liabilities	$1.887M	$3.040M	$3.040M
YoY Change	11.94%	134.6%	134.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$63.22M	-$62.73M
YoY Change	6.3%	16.94%
Common Stock	$240.0K	$230.9K
YoY Change	49.98%	43.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.078M	-$2.229M	-$2.229M
YoY Change
Total Liabilities & Shareholders Equity	$809.0K	$811.5K	$811.5K
YoY Change	5.35%	12.18%	12.18%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$491.0K	-$1.085M	-$9.087M
YoY Change	-91.58%	-81.37%	-72.11%
Depreciation, Depletion And Amortization	$0.00		$0.00
YoY Change
Cash From Operating Activities	-$675.2K	-$223.8K	-$1.124M
YoY Change	134.75%	88.47%	34.12%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$4.180K	$130.7K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$4.180K	-$130.7K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	675.4K	131.5K	$1.242M
YoY Change	132.9%	5.23%	71.24%
NET CHANGE
Cash From Operating Activities	-675.2K	-223.8K	-$1.124M
Cash From Investing Activities	0.000	-4.180K	-$130.7K
Cash From Financing Activities	675.4K	131.5K	$1.242M
Net Change In Cash	190.0	-96.39K	-$13.48K
YoY Change	-91.98%	-1634.87%	-88.09%
FREE CASH FLOW
Cash From Operating Activities	-$675.2K	-$223.8K	-$1.124M
Capital Expenditures	$0.00	$4.180K	$130.7K
Free Cash Flow	-$675.2K	-$227.9K	-$1.255M
YoY Change	134.75%		49.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001575858
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
CY2022	PUBC	Stock Issued During Period Value Settlement Share Surrender StockIssuedDuringPeriodValueSettlementShareSurrender		usd
CY2023	PUBC	Stock Issued During Period Value Settlement Share Surrender StockIssuedDuringPeriodValueSettlementShareSurrender		usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2022	PUBC	Gain Loss On Debt Forgiveness GainLossOnDebtForgiveness		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	PUBC	Increase Decrease In Settlement Liability IncreaseDecreaseInSettlementLiability		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	PUBC	Due To Affiliates Exchanged For Convertible Debt DueToAffiliatesExchangedForConvertibleDebt		usd
CY2023	PUBC	Convertible Debt Converted To Common Stock ConvertibleDebtConvertedToCommonStock		usd
CY2022	PUBC	Expenses Paid For On Behalf Of Company ExpensesPaidForOnBehalfOfCompany		usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2023	us-gaap	Sublease Income SubleaseIncome		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2022	us-gaap	Sublease Income SubleaseIncome		usd
CY2022Q4	PUBC	Accrued Consultants AccruedConsultants		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-11-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--11-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-55517
CY2023	dei	Entity Registrant Name EntityRegistrantName	PUREBASE CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-2060863
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	8631 State Highway
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	124
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Ione
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95640
CY2023	dei	City Area Code CityAreaCode	(209)
CY2023	dei	Local Phone Number LocalPhoneNumber	274-9143
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	8163891	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	239740928	shares
CY2023	dei	Auditor Firm AuditorFirmId	76
CY2023	dei	Auditor Name AuditorName	Turner, Stone & Company, L.L.P
CY2023	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5572	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19055	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15434	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4731	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	21006	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	23786	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	750716	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	620000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39799	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79599	usd
CY2023Q4	us-gaap	Assets Assets	811521	usd
CY2022Q4	us-gaap	Assets Assets	723385	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	481024	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	115478	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	618000	usd
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	400000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	346735	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	40880	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38882	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	19000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	36000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1514355	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	644076	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	40880	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1525676	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	610889	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3040031	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1295845	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	520000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	520000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	230863005	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	230863005	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	230753005	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	230753005	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	230863	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	160350	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60271605	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52910839	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62730978	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53643649	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2228510	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-572460	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	811521	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	723385	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	325875	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	471608	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	96148	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	132247	usd
CY2023	us-gaap	Gross Profit GrossProfit	229727	usd
CY2022	us-gaap	Gross Profit GrossProfit	339361	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1541238	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1261495	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	7391278	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	31622178	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	8932516	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	32883673	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-8702789	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-32544312	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	310401	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2007	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	618000	usd
CY2023	us-gaap	Interest Expense InterestExpense	76941	usd
CY2022	us-gaap	Interest Expense InterestExpense	40120	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-384540	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38113	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9087329	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-32582425	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	230731334	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	230731334	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228296555	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	228296555	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2185384	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	31622178	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2573171	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-32582425	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-572460	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-572460	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	7387279	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8000	usd
CY2023	PUBC	Conversion Of Board Of Director Accrued Debt ConversionOfBoardOfDirectorAccruedDebt	36000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9087329	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2228510	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2228510	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	215380751	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9087329	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-32582425	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	7391278	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	31622178	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5329	usd
CY2023	us-gaap	Officers Compensation OfficersCompensation	19000	usd
CY2022	us-gaap	Officers Compensation OfficersCompensation	36000	usd
CY2023	PUBC	Gain Loss On Debt Forgiveness GainLossOnDebtForgiveness	35401	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	275000	usd
CY2023	PUBC	Right Of Use Asset And Liability Net RightOfUseAssetAndLiabilityNet	-918	usd
CY2022	PUBC	Right Of Use Asset And Liability Net RightOfUseAssetAndLiabilityNet	293	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6703	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	137	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	375947	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	79094	usd
CY2023	PUBC	Increase Decrease In Settlement Liability IncreaseDecreaseInSettlementLiability	-493000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1124290	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-838254	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	130716	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-130716	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	914788	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	755000	usd
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	346735	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	20000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	30000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1241523	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	725000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13483	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-113254	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19055	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	132309	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5572	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19055	usd
CY2022	PUBC	Due To Affiliates Exchanged For Convertible Debt DueToAffiliatesExchangedForConvertibleDebt	1495382	usd
CY2022	PUBC	Convertible Debt Converted To Common Stock ConvertibleDebtConvertedToCommonStock	2464262	usd
CY2023	PUBC	Board Of Director Compensation Accrued As Convertible Debt BoardOfDirectorCompensationAccruedAsConvertibleDebt	19000	usd
CY2022	PUBC	Board Of Director Compensation Accrued As Convertible Debt BoardOfDirectorCompensationAccruedAsConvertibleDebt	36000	usd
CY2023	PUBC	Vendors Paid For On Behalf Of Company VendorsPaidForOnBehalfOfCompany	15853	usd
CY2022	PUBC	Vendors Paid For On Behalf Of Company VendorsPaidForOnBehalfOfCompany	11323	usd
CY2023	PUBC	Expenses Paid For On Behalf Of Company ExpensesPaidForOnBehalfOfCompany	23029	usd
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2010-03-02
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62730978	usd
CY2023Q4	PUBC	Working Capital Deficit WorkingCapitalDeficit	-1493349	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9087329	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1124290	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	914788	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zSFjcybPniSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zDtm8g0g3G64">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and equity-based transactions at the date of the financial statements and the revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the consolidated financial statements. Significant estimates include the allowance for doubtful accounts, useful lives of property and equipment, deferred tax asset and valuation allowance, and assumptions used in the Black-Scholes valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	325875	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	471608	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	PUBC	Property Equipment Excluding Plant PropertyEquipmentExcludingPlant	620000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	130716	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	67165	usd
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	3543	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	15040	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	138320342	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	130478974	shares
CY2023Q4	us-gaap	Area Of Land AreaOfLand	700	sqft
CY2023	us-gaap	Payments For Rent PaymentsForRent	3500	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	817880	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	687164	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	67164	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	67164	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	750716	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	620000	usd
CY2023	us-gaap	Depreciation Depreciation	0	usd
CY2022	us-gaap	Depreciation Depreciation	0	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	42000	usd
CY2023	us-gaap	Lease Cost LeaseCost	42000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	42000	usd
CY2023	PUBC	Operating Lease Operating Cash Flows Liability Reduction OperatingLeaseOperatingCashFlowsLiabilityReduction	38882	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39799	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	40880	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	20000	usd
CY2022	us-gaap	Lease Cost LeaseCost	20000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	20000	usd
CY2022	PUBC	Operating Lease Operating Cash Flows Liability Reduction OperatingLeaseOperatingCashFlowsLiabilityReduction	19248	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79599	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38882	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	40880	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	42000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	42000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1120	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	40880	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.04
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	314502	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	30078	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	120011	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	57266	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	39080	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	28134	usd
CY2023Q4	PUBC	Accrued Consultants AccruedConsultants	7431	usd
CY2023Q4	PUBC	Accounts Payable And Accrued Expenses AccountsPayableAndAccruedExpenses	481024	usd
CY2022Q4	PUBC	Accounts Payable And Accrued Expenses AccountsPayableAndAccruedExpenses	115478	usd
CY2022Q3	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	2464261	usd
CY2022Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	108910	usd
CY2022Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	23741654	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	117795000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.39
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10893187	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	128688187	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.53
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	750000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.13
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	129438187	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.53
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	129438187	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M4D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.53
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	129438187	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P10Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	914788	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	755000	usd
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	75346	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3260600	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2692900	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3260600	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2692900	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3260600	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2692900	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	567700	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2266900	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.07	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.07	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.08	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.07	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.20	pure

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-008171-index-headers.html	Edgar Link	pending
0001493152-24-008171-index.html	Edgar Link	pending
0001493152-24-008171.txt	Edgar Link	pending
0001493152-24-008171-xbrl.zip	Edgar Link	pending
audit_001.jpg	Edgar Link	pending
audit_002.jpg	Edgar Link	pending
ex10-43.htm	Edgar Link	pending
ex10-43_001.jpg	Edgar Link	pending
ex10-43_002.jpg	Edgar Link	pending
ex10-43_003.jpg	Edgar Link	pending
ex10-43_004.jpg	Edgar Link	pending
ex10-43_005.jpg	Edgar Link	pending
ex10-43_006.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
form10-k_003.jpg	Edgar Link	pending
form10-k_004.jpg	Edgar Link	pending
form10-k_005.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pubc-20231130.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
pubc-20231130_def.xml	Edgar Link	unprocessable
pubc-20231130_lab.xml	Edgar Link	unprocessable
pubc-20231130_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pubc-20231130_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PUBC
PureBase Corp Stock $pubc

2024 Q1 Form 10-K Financial Statement

#000149315224008171 Filed on February 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PUBC PureBase Corp Stock $pubc

2024 Q1 Form 10-K Financial Statement

#000149315224008171 Filed on February 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PUBC
PureBase Corp Stock $pubc